Zurcher Kantonalbank (Zurich Cantonalbank) Exelixis, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Exelixis, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 63,447 shares of EXEL stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
63,447
Previous 60,098
5.57%
Holding current value
$2.39 Million
Previous $1.56 Million
35.47%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding EXEL
# of Institutions
565Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.11 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$882 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$576 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$430 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...